Cutting edge: Liposomal formulation of a self lymphoma antigen induces potent protective antitumor immunity

Journal of Immunology

Volumn 160, Issue 8, 1998, Pages 3637-3641

  Kwak, Larry W ^a,d   Pennington, Robin ^a   Boni, Larry ^b   Ochoa, Augusto C ^c,e   Robb, Richard J ^b   Popescu, Mircea C ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Biomira USA Inc   (United States)

^c SAIC FREDERICK INC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; LIPOSOME; LYMPHOMA ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG; ALLOANTIGEN; CANCER VACCINE; IMMUNOGLOBULIN IDIOTYPE; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER PREVENTION; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LETHAL DOSE; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNOLOGY; VACCINATION; ANIMAL; C3H MOUSE; CANCER TRANSPLANTATION; IMMUNIZATION; IMMUNOLOGY; IN VITRO STUDY; ISOGRAFT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN IDIOTYPES; INTERLEUKIN-2; ISOANTIGENS; LIPOSOMES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; LYMPHOMA; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, ISOGENEIC;

EID: 0032521906     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Chen, L., P. McGowan, S. Ashe, J. Johnston, Y. Li, I. Hellstrom, and K. E. Hellstrom. 1994. Tumor immunogenicity determines the effect of B7 co-stimulation on T cell-mediated tumor immunity. J. Exp. Med. 179:523.
2. Dranoff G., E. Jaffee, A. Lazenby, P. Golumber, H. Levitsky, K. Brose, V. Jackson, H. Hamada, D. Pardoll, and R. C. Mulligan. 1993. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90:3539.
3. Rock, K. L., S. Gamble, and L. Rothstein. 1990. Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science 249:918.
4. Stevenson, G. T., and F. K. Stevenson. 1975. Antibody to molecularly defined antigen confined to a tumor cell surface. Nature 254:714.
5. Lynch, R. G., R. J. Graff, S. Sirisinha, E. S. Simms, and H. N. Eisen. 1972. Myeloma proteins as tumor-specific transplantation antigens. Proc. Natl. Acad. Sci. USA 69:1540.
6. L domain of the isologous myeloma protein 315 inhibits growth of mouse plasmacytoma MOPC315. Scand. J. Immunol. 11:29.
7. Bridges, S. H. 1978. Participation of the humoral immune system in the myeloma-specific transplantation resistance. J. Immunol. 121:479.
8. 1 mice. J. Exp. Med. 140:1547.
9. 1. J. Immunol. 138:628.
10. Kaminski, M. S., K. Kitamura, D. G. Maloney, and R. Levy. 1987. Idiotype vaccination against murine B cell lymphoma: inhibition of tumor immunity by free idiotype protein. J. Immunol. 138:1289.
11. Kwak, L. W., M. J. Campbell, D. Czerwinski, S. Hart, R. A. Miller, and R. Levy. 1992. Induction of immune responses in patients with B-cell lymphoma against the surface immunoglobulin idiotype expressed by their tumors. N. Engl. J. Med. 327:1209.
12. Campbell, M. J., L. Esserman, N. E. Byars, A. C. Allison, and R. Levy. 1990. Idiotype vaccination against murine B cell lymphoma: humoral and cellular requirements for the full expression of antitumor immunity. J. Immunol. 145: 1029.
13. Lasic, D. D., and D. Papahadjopoulos. 1995. Liposomes revisited. Science 267:1275.
14. Bergman, Y., and J. Haimovich. 1977. Characterization of a carcinogen-induced murine B lymphocyte cell line of C3H/eb origin. Eur. J. Immunol. 7:413.
15. Eshhar, Z., C. Blatt, Y. Bergman, and J. Haimovich. 1979. Induction of secretion of IgM from cells of the B cell line 38C-13 by somatic cell hybridization. J. Immunol. 122:2430.
16. Anderson, P. M., D. Hasz, L. Dickrell, and S. Spencer. 1992. Interleukin-2 in liposomes: increased intravenous potency and less pulmonary toxicity in the rat. Drug Dev. Res. 27:15.
17. Suonpaa, M., E. Markela, T. Stahlberg, and I. Hemmila. 1992. Europium-labelled streptavidin as a highly sensitive universal label. J. Immunol. Methods 149:247.
18. Kwak, L. W., H. A. Young, R. W. Pennington, and S. W. Weeks. 1996. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response. Proc. Natl. Acad. Sci. USA 93:10972.
19. Harding, C. V., D. S. Collins, J. W. Slot, H. J. Geuze, and E. R. Unanue. 1991. Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells. Cell 64:393.
20. Reddy, R., F. Zhou, S. Nair, L. Huang, and B. T. Rouse. 1992. In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes. J. Immunol. 148:1585.
21. Kwak, L. W., D. D. Taub, P. L. Duffey, W. I. Bensinger, E. M. Bryant, C. W. Reynolds, and D. L. Longo. 1995. Transfer of myeloma idiotype-specific immunity from an actively immunized marrow donor. Lancet 345:1016.
22. Tao, M.-H., and R. Levy. 1993. Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature 362:755.
23. Hawkins, R. E., G. Winter, T. J. Hamblin, F. K. Stevenson, and S. J. Russell. 1993. A genetic approach to idiotypic vaccination. J. Immunother. 14:273.
24. Syrengelas, A. D., T. T. Chen, and R. Levy. 1996. DNA immunization induces protective immunity against B-cell lymphoma. Nat. Med. 2:1038.
25. Flamand, V., T. Sornasse, K. Thielemans, C. Demanet, M. Bakkus, H. Bazin, F. Thielemans, O. Leo, J. Urbain, and M. Moser. 1994. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24:605.
26. H epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes. J. Exp. Med. 179: 95.
27. Kruisbeek, A. M. 1991. In vivo assays for mouse lymphocyte function. In Current Protocols in Immunology, J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, and E. M. Shevach, eds. Wiley, New York, p. 4.1.1.